Johnson & Johnson announced data to support boosting its single-shot COVID-19 vaccine
On Aug. 25, 2021, Johnson & Johnson announced data supporting the use of its COVID-19 vaccine as a…
US Department of Defense awarded $14.7 million contract to SteriPack to establish production capability of ExpressCollect collection devices
On Aug. 25, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
Medigen Vaccine Biologics announced launch of COVID-19 vaccine MVC-COV1901 with Dynavax’s CpG 1018 adjuvant
On Aug. 23, 2021, Dynavax Technologies and Biological E announced the execution of a commercial supply agreement of…
Lab studies suggested InBios COVID-19 POC antigen detection test will detect Delta variant
On Aug. 22, 2021, InBios announced that laboratory studies suggest its SCoV-2 Ag Detect Rapid Test detected the…
UK authorized Regeneron antibody cocktail to prevent and treat acute COVID-19 infection
On Aug. 20, 2021, Regeneron announced that the United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency had…
clinical trial tested donated antibodies for effectiveness in fighting infection caused by Coronavirus
On Aug. 19, 2021, Oregon Health & Science University (OHSU) announced that it was part of a randomized,…
Researchers developed COVID-19 severity screening method based on the Agilent Cary 630 FTIR spectrometer
On Aug. 18, 2021, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
NIH study showed no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms
On Aug. 18, 2021, the final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)…
Relief announced positive safety report for ZYESAMI(TM) (aviptadil) in ACTIV-3 critical care study in patients with COVID-19
On Aug. 18, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals,…
UK announced tender opportunity for providers to manage, genotype, and store Our Future Health biological samples
On Aug. 17, 2021, Our Future Health published a new tender for the processing, genotyping, and storage of…
ADMA Biologics received FDA approval for plasma collection facility in Maryville, TN
On Aug. 16, 2021, ADMA Biologics announced that it had received U.S. Food and Drug Administration approval for…
Second-Gen mRNA COVID-19 vaccine candidate demonstrated improved immune response in preclinical study
On Aug. 16, 2021, CureVac and GSK announced publication on the preprint server bioRxiv of preclinical data investigating…
NIH scientists developed faster COVID-19 test
On Aug. 16, 2021, scientists at the National Institutes of Health (NIH) announced they had developed a new…
Pfizer and BioNTech announced submission of initial data to FDA to support booster dose of COVID-19 vaccine
On Aug. 16, 2021, Pfizer and BioNTech announced that they had submitted Phase 1 data to the U.S….
Cote d’Ivoire declared first Ebola outbreak in more than 25 years
On Aug. 14, 2021, the Ministry of Health of Cote d’Ivoire confirmed the country’s first case of Ebola…
COVID-19 | FDA | Life Science History | NIH
FDA declined to issue Rigel Pharma EUA for fostamatinib for teatment of COVID-19 in hospitalized adults
On Aug. 13, 2021, Rigel Pharma announced that the U.S. Food and Drug Administration (FDA) had informed the…
U.S. FDA approved TICOVACﾙ, Pfizerﾒs tick-borne encephalitis vaccine
On Aug. 13, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved TICOVACﾙ (tick-borne…
Monoclonal antibody prevented malaria in small NIH trial
On Aug. 11, 2021, the National Institutes of Health (NIH) announced that one dose of a new monoclonal…
NIH launched study of third COVID-19 vaccine dose in kidney transplant recipients
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
Cardinal Health partnered with Abbott and Quidel to offer rapid OTC COVID-19 tests
On Aug. 10, 2021, Cardinal Health announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19…
FDA approved new treatment for Pompe Disease
On Aug. 6, 2021, the U.S. Food and Drug Administration approved Genzyme’s Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion…
CDC reported vaccination offers higher protection than previous COVID-19 infection
On Aug. 6, 2021, the Centers for Disease Control and Prevention (CDC) annouced in MMWR that a study…
NIH-funded study discovered gene involved in male infertility
On Aug. 5, 2021, an international team of researchers announced that a mutation in a single gene appeared…
Lenzilumab treatment may provide enhanced likelihood of survival without ventilation in hospitalized black and African-American COVID-19 patients
On Aug. 4, 2021, Humanigen announced analysis of results from its Phase 3 LIVE-AIR study of lenzilumab in…
Bio-Techne’s RNAscopeﾙ aids in tissue diagnosis of COVID-19 in cases with no previous SARS-CoV-2 testing
On Aug. 4, 2021, Bio-Techne announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC)…
Vanda closed enrollment in ODYSSEY study comparing tradipitant and placebo In COVID-19 pneumonia patients
On Aug. 3, 2021, Vanda Pharmaceuticals announced that enrollment had closed in the ODYSSEY study comparing tradipitant and…
Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
On Aug. 3, 2021, Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients…
FDA cleared Vaxart’s IND application for S-only oral tablet COVID-19 vaccine candidate
On Aug. 2, 2021, Vaxart announced that the U.S. Food and Drug Administration had cleared Vaxart’s Investigational New…
MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South Africa
On Jul. 30, 2021, the Medicines Patent Pool and the World Health Organization, Afrigen Biologics, the Biologicals and…
NIH advanced ACTIV-5/BET-B trial evaluating lenzilumab from phase 2 study to phase 2/3 trail for treatment of COVID-19
On Jul. 30, 2021, Humanigen announced that the NIH had advanced the ACTIV-5/BET-B study to a Phase 2/3…